What Is SLU-PP-332 and Why Is It Getting So Much Attention?

Introduction

What is SLU-PP-332? It's an experimental compound attracting attention because researchers are studying whether activating estrogen-related receptors (ERRs) can influence mitochondrial function, energy metabolism, and some of the molecular adaptations associated with exercise.

That description needs an important qualifier: SLU-PP-332 is still a preclinical research compound. Much of the attention surrounding it comes from laboratory and animal studies—not established human clinical evidence.

Researchers are interested in SLU-PP-332 because ERRs help regulate genes involved in cellular energy metabolism. Rather than acting like familiar incretin-based compounds, SLU-PP-332 is being investigated through an entirely different biological pathway.

That makes it particularly relevant to research involving mitochondrial activity and metabolic health. MHS Longevity's Longevity resources and Longevity Peptides collection provide additional context for related areas of longevity research.

Research disclaimer: SLU-PP-332 is an experimental research compound and is not FDA-approved for treating, preventing, or curing disease. MHS Longevity products discussed here are intended for laboratory research purposes only and are not approved for human consumption.

SLU-PP-332 is a synthetic experimental compound developed to activate the estrogen-related receptor family, including ERRα, ERRβ, and ERRγ.

ERRs are nuclear receptors involved in regulating genes associated with cellular energy production and metabolism. They are particularly relevant in tissues with substantial energy demands, such as skeletal muscle and the heart.

This connection to cellular energy regulation is a major reason what is SLU-PP-332 has become an increasingly common research question.

Additional compound-specific information is available through MHS Longevity's SLU-PP-332 1000mcg research page.

SLU-PP-332 acts as an agonist of estrogen-related receptors. An agonist essentially activates its receptor, influencing downstream biological signaling.

ERRα is especially important to the research surrounding SLU-PP-332 because it helps control transcriptional programs associated with mitochondrial function, oxidative metabolism, and energy utilization.

A study published in the American Chemical Society's ACS Chemical Biology described SLU-PP-332 as a pan-ERR agonist and investigated its ability to enhance an acute aerobic exercise response in mice.

Put simply, researchers are investigating whether activating these receptors can turn up certain metabolic programs normally associated with high energy demand.

The name can be confusing.

Estrogen-related receptors are not conventional estrogen receptors. ERRs are called “orphan nuclear receptors” and have important functions involving mitochondrial biogenesis, oxidative metabolism, and cellular energy homeostasis.

That makes them attractive research targets when scientists are investigating questions such as:

SLU-PP-332 gives researchers a way to experimentally activate these pathways and observe what happens downstream.

This is where much of the buzz comes from.

Research in mice has suggested that pharmacologically activating ERR signaling can produce some molecular and metabolic effects associated with aerobic exercise.

In the ACS study, SLU-PP-332 increased oxidative skeletal muscle fibers and improved exercise endurance in mice. Researchers subsequently investigated ERR activation in additional metabolic contexts.

This has led to the phrase “exercise mimetic.”

But that label needs context.

SLU-PP-332 has not been demonstrated to reproduce all the effects of exercise in humans, and calling it “exercise in a pill” dramatically oversimplifies the science. Exercise influences the cardiovascular, musculoskeletal, neurological, endocrine, and immune systems in ways that cannot be reduced to one receptor pathway.

The interesting question isn't whether SLU-PP-332 makes exercise obsolete. It's what ERR activation can teach researchers about specific metabolic adaptations associated with exercise.

Mitochondria produce much of the usable energy required by cells, making their function central to metabolism and cellular health.

ERR signaling helps regulate genes associated with mitochondrial biogenesis and oxidative energy metabolism. Activating these receptors therefore gives researchers another route for studying how mitochondrial activity responds to changes in metabolic demand.

This puts SLU-PP-332 within a broader field of mitochondrial research that includes very different compounds and pathways.

For example, MHS Longevity also provides research information on MOTS-C 40mg and SS-31 50mg, two compounds frequently discussed in mitochondrial research despite having mechanisms distinct from SLU-PP-332.

For a broader overview of the biology involved, see Mitochondrial Function & Cellular Health.

These compounds sometimes appear in the same longevity conversations, but they shouldn't be treated as interchangeable.

SLU-PP-332 therefore represents a different research strategy. Instead of being a mitochondrial-derived or mitochondria-targeting peptide, it acts on nuclear receptors that regulate metabolic gene expression.

Researchers interested specifically in the differences between the latter two compounds can also read SS-31 vs. MOTS-C.

Research into SLU-PP-332 remains predominantly preclinical.

Published mouse studies have investigated its effects on exercise endurance, skeletal muscle metabolism, energy expenditure, fat accumulation, and metabolic function. These findings have helped make ERR agonism an interesting area for further investigation.

However, this is exactly where responsible interpretation matters.

Results in mice do not establish safety or effectiveness in humans.

The available research doesn't justify treating SLU-PP-332 as a proven weight-loss compound, exercise replacement, anti-aging therapy, or treatment for metabolic disease.

Several factors have converged:

But the most scientifically interesting part of what is SLU-PP-332 isn't the hype.

It's the possibility that ERR agonists can help researchers better understand how gene regulation, mitochondrial activity, skeletal muscle, and whole-body energy metabolism interact.

Anyone exploring mitochondrial research should also remember that compounds are only one part of the picture. MHS Longevity's guide to Mitochondrial Health Habits covers the broader relationship between lifestyle and mitochondrial health.